[Skip to Content]
[Skip to Content Landing]
Views 189
Citations 0
January 9, 2019

Diagnostic Criteria and Phenotypes of Pemphigoid and the Association With Gliptins

Author Affiliations
  • 1Department of Dermatology, St George Hospital, University of New South Wales, Sydney, New South Wales, Australia
JAMA Dermatol. Published online January 9, 2019. doi:10.1001/jamadermatol.2018.4847

In this issue, there are 2 excellent large retrospective studies from single centers in Groningen, The Netherlands,1 and Haifa, Israel2 of patients referred for possible bullous pemphigoid (BP). In addition, there is a nationwide population-based study from Korea evaluating the risk of BP in patients with diabetes receiving dipeptidyl peptidase 4 inhibitors (gliptins).3